Gilead sues alleged counterfeit ring over US-wide fake HIV meds plot

Gilead Sciences has sued an array of pharmaceutical suppliers and distributors accusing them of forming a counterfeiting network and allegedly selling fake versions of its HIV medications.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Big pharma firm settles HIV drug disputes with generic makers

13 September 2022 Gilead had filed patent infringement proceedings lawsuit against five companies | Drug makers will receive non-exclusive licences starting from Halloween 2031.

Big Pharma

Antitrust HIV drugs case should be arbitrated, argue Gilead, BMS

16 February 2021 Gilead Sciences and Bristol-Myers Squibb have said that a suit alleging they were involved in a long-running scheme to block generic competition and keep HIV medication prices artificially high is “legally defective”.

Big Pharma

Russian drugmakers bypass Gilead to unveil COVID-19 generic

4 February 2021 Russian pharmaceutical company Pharmsynthez has allegedly started producing a generic version of COVID-19 drug remdesivir without the authorisation of the drug’s patent owner, Gilead Sciences.

More on this story

Americas

Big pharma firm settles HIV drug disputes with generic makers

13 September 2022 Gilead had filed patent infringement proceedings lawsuit against five companies | Drug makers will receive non-exclusive licences starting from Halloween 2031.

Big Pharma

Antitrust HIV drugs case should be arbitrated, argue Gilead, BMS

Big Pharma

Russian drugmakers bypass Gilead to unveil COVID-19 generic

More on this story

Americas

Big pharma firm settles HIV drug disputes with generic makers

13 September 2022 Gilead had filed patent infringement proceedings lawsuit against five companies | Drug makers will receive non-exclusive licences starting from Halloween 2031.

Big Pharma

Antitrust HIV drugs case should be arbitrated, argue Gilead, BMS

Big Pharma

Russian drugmakers bypass Gilead to unveil COVID-19 generic